The inventions is directed to purified and isolated novel murine and human kinase
polypeptides, the nucleic acid encoding such polypeptides, processes for production
of recombinant forms of such polypeptides, antibodies generated against these polypeptides,
fragmented peptides derived from these polypeptides, and the uses of the above.